CVSI
Healthcare Drug Manufacturers - Specialty & GenericCV Sciences, Inc.
$0.01
+0.00 +40.00% today
Price History
Not enough data
Key Stats
Market Cap
3.16M
Avg Volume
609,159
EPS
-$0.02
52W High
$0.10
52W Low
$0.01
Div. Yield
0.0%
Valuation
Forward P/E
-0.35
P/B Ratio
2.00
P/S Ratio
0.25
EV/EBITDA
-4.86
EV/Revenue
0.33
Margins
Gross Margin 49.1%
Operating Margin (10.1%)
Net Margin (15.7%)
EBITDA Margin (6.8%)
Growth & Returns
Revenue Growth (YoY)
(17.5%)
Return on Equity
(118.9%)
Return on Assets
(8.4%)
Liquidity & Leverage
Current Ratio
0.99
Quick Ratio
0.12
Debt / Equity
0.80
Total Cash
266,000
Total Debt
1.25M
About
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
www.cvsciences.com